Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study
Surendra K. Sharma(Jamia Hamdard), NK Mehra(Indian Institute of Management Ahmedabad), Pradip Kumar Saha(Post Graduate Institute of Medical Education and Research), R. M. Pandey(All India Institute of Medical Sciences), Arumugam Balamurugan(University of California, Los Angeles), V M Katoch(National JALMA Institute for Leprosy & Other Mycobacterial Diseases), Neeru Jain(Veer Narmad South Gujarat University), Kiran K. Turaga(Yale New Haven Hospital)
Cited by 71
Related Papers
Microwave Ablation for Hepatic Malignancies
|Annals of Surgery|2013|254
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: A Systematic Review and Meta-analysis
|Annals of Surgical Oncology|2014|252
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis
|The Lancet Global Health|2022|210
Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma
|Journal of Surgical Oncology|2014|184